Defects in insulin receptor signaling in vivo in the polycystic ovary syndrome (PCOS). (Q43664600)

25 November 2017

Defects in insulin receptor signaling in vivo in the polycystic ovary syndrome (PCOS). (English)

1 reference

polycystic ovary syndrome

25 November 2017

1 reference

1 reference

1 reference

Evanthia Diamanti-Kandarakis

series ordinal

4

object named as

Diamanti-Kandarakis E

1 reference

25 November 2017

Dunaif A

1

1 reference

25 November 2017

Wu X

series ordinal

2

1 reference

25 November 2017

Lee A

series ordinal

3

1 reference

25 November 2017

1 August 2001

1 reference

American Journal of Physiology - Endocrinology and Metabolism

25 November 2017

1 reference

25 November 2017

281

1 reference

25 November 2017

2

1 reference

25 November 2017

E392-9

1 reference

Insulin receptor substrate-1 phosphorylation and phosphatidylinositol 3-kinase activity in skeletal muscle from NIDDM subjects after in vivo insulin stimulation

25 November 2017

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.281.2.E392

Phosphatidylinositol 3-kinase activation is required for insulin stimulation of pp70 S6 kinase, DNA synthesis, and glucose transporter translocation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.281.2.E392

Exercise-induced changes in expression and activity of proteins involved in insulin signal transduction in skeletal muscle: differential effects on insulin-receptor substrates 1 and 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.281.2.E392

Insulin resistance differentially affects the PI 3-kinase- and MAP kinase-mediated signaling in human muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.281.2.E392

Protein kinase C modulation of insulin receptor substrate-1 tyrosine phosphorylation requires serine 612.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.281.2.E392

Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.281.2.E392

Excessive insulin receptor serine phosphorylation in cultured fibroblasts and in skeletal muscle. A potential mechanism for insulin resistance in the polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.281.2.E392

Impaired glucose transport and insulin receptor tyrosine phosphorylation in skeletal muscle from obese women with gestational diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.281.2.E392

Structure, regulation and function of phosphoinositide 3-kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.281.2.E392

Insulin receptor phosphorylation, insulin receptor substrate-1 phosphorylation, and phosphatidylinositol 3-kinase activity are decreased in intact skeletal muscle strips from obese subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.281.2.E392

The inherent quantitative capacity of the reverse transcription-polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.281.2.E392

Defect in skeletal muscle phosphatidylinositol-3-kinase in obese insulin-resistant mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.281.2.E392

Insulin activation of phosphatidylinositol 3-kinase in human skeletal muscle in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.281.2.E392

IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.281.2.E392

Insulin-stimulated GLUT4 translocation is relevant to the phosphorylation of IRS-1 and the activity of PI3-kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.281.2.E392

Tissue-specific insulin resistance in mice with mutations in the insulin receptor, IRS-1, and IRS-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.281.2.E392

Normal insulin-dependent activation of Akt/protein kinase B, with diminished activation of phosphoinositide 3-kinase, in muscle in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.281.2.E392

Membrane glycoprotein PC-1 and insulin resistance in non-insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.281.2.E392

Evaluation of WHO and NDDG criteria for impaired glucose tolerance. Results from two national samples.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.281.2.E392

Signaling pathways in insulin action: molecular targets of insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.281.2.E392

Insulin receptor substrate (IRS) 1 is reduced and IRS-2 is the main docking protein for phosphatidylinositol 3-kinase in adipocytes from subjects with non-insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.281.2.E392

Insulin resistance in polycystic ovary syndrome: decreased expression of GLUT-4 glucose transporters in adipocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.281.2.E392

Insulin signaling in insulin receptor substrate (IRS)-1-deficient brown adipocytes: requirement of IRS-1 for lipid synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.281.2.E392

Protein-protein interaction in insulin signaling and the molecular mechanisms of insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.281.2.E392

Formation of phosphatidylinositol 3-phosphate by isomerization from phosphatidylinositol 4-phosphate

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.281.2.E392

Disruption of IRS-2 causes type 2 diabetes in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.281.2.E392

Characterization of signal transduction and glucose transport in skeletal muscle from type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2001.281.2.E392

10.1152/AJPENDO.2001.281.2.E392

21 January 2018

Identifiers

DOI

0 references

1 reference